TY - JOUR T1 - Sustained seroprevalence of anti SARS-CoV-2 total immunoglobulins in asymptomatic blood donors JF - medRxiv DO - 10.1101/2021.04.28.21256242 SP - 2021.04.28.21256242 AU - M Carmen Martín AU - M Isabel González AU - Nuria Holgado AU - Ana I Jimenez AU - Nuria Ortega AU - Isabel Page AU - Alba Parrado AU - María Pérez AU - Lydia Blanco-Peris Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/05/01/2021.04.28.21256242.abstract N2 - Background Seroprevalence analysis of SARS-CoV-2 is one of the keys to accurately monitor pandemics and help the authorities make health decisions and adjust the current social interventions. The aim of this study was to determine retrospective seroprevalence evolution among blood donors along prepandemic months, and the first wave in Spain. A secondary objective was to determine whether age, blood group or haematological parameters are related to recent past infection.Material and Methods A total of 12719 donations SARS-CoV-2 from July 2019 to October 2020 were analysed. Donors were 60.9% males and their average age was 46+/-13. An automated chemiluminiscence double-antigen sandwich immunoassay for the in vitro semi quantitative detection of total antibodies to SARS-CoV-2 in human serum and plasma was performed.Results Seropositivity donation rate grew up from week 11 to week 21, reaching plateau by near 8% donations, sustained until week 43 when 2nd wave arose in our country. 6.7% individuals were positive by the end of 1st wave. No differences by sex age or blood group were found regarding antibodies. Lymphocyte were significantly higher in positive woman as compared to negative ones and haemoglobin were lower in positive men as compared to negative ones.Discussion Seroprevalence due to asymptomatic cases would be equivalent to that of general population. Sex and age would not affect COVID-19 susceptibility but its severity. Gender differences are present even in asymptomatic individuals: females are possibly protected by their relative lymphocytosis and neutropenia whereas males are would be weaker as seropositive men show a decrease of haematocrit and haemoglobin. Further studies are needed to confirm these gender differences not only in severe but as well in asymptomatic cases as they can help better understand COVID19 pathogenesis and prognosis.Competing Interest StatementThis work has been carried out provided free equipment and test reagents from Roche Diagnostics International Ltd. M Carmen Martin spoke about this issue in a sponsored symposium of Roche Diagnostics International Ltd.Funding StatementThis work has been carried out provided free equipment and test reagents from Roche Diagnostics International Ltd.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted according with national regulations, institutional policies and in the tenets of the Helsinki Declaration. This study was approved, with the Valladolid Health Area Drug Research Ethics Committee acting as the main committee, in a meeting held on June 11, 2020 with the reference number BIO-2020-93All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData collected for the study, including fully anonymized participant data, are available to others. Data available include fully anonymized participant data and data dictionary. Related documents are available from the date of publications henceforth: study protocol, statistical analysis, and approval of Ethical Board. These documents are available from the date of publications henceforth at email address cmartinalo{at}saludcastillayleon.es. Data would be shared after approval of proposals by the Valladolid Este Ethical Committee. ER -